122 related articles for article (PubMed ID: 22655494)
1. One-year observation of inflammatory markers in patients with aortic valve stenosis.
Swierszcz J; Dubiel JS; Krzysiek J; Sztefko K
J Heart Valve Dis; 2011 Nov; 20(6):639-49. PubMed ID: 22655494
[TBL] [Abstract][Full Text] [Related]
2. One-year observation of inflammatory markers in patients with aortic valve stenosis who expressed high or low Chlamydia pneumoniae antibody titers.
Swierszcz J; Jacek DS; Milewicz T; Krzysiek J; Sztefko K; Galicka-Latała D
J Heart Valve Dis; 2012 Sep; 21(5):599-607. PubMed ID: 23167224
[TBL] [Abstract][Full Text] [Related]
3. [One year observation of natural course of aortic valve stenosis in patients with normal and abnormal lipoprotein (a) plasma level].
Swierszcz J; Dubiel JS; Milewicz T; Sztefko K; Galicka-Latała D; Pfitzner R; Wodniecki J; Krzysiek J
Przegl Lek; 2010; 67(3):161-4. PubMed ID: 20687376
[TBL] [Abstract][Full Text] [Related]
4. [Smoking, increase in plasma lipoprotein (a) and triglycerides, as well as decrease in plasma HDL-cholesterol concentrations seem to be linked with aortic valve stenosis and its progression].
Swierszcz J; Dubiel JS; Milewicz T; Sztefko K; Krzysiek J
Przegl Lek; 2009; 66(4):159-65. PubMed ID: 19708503
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of echocardiographic findings in AVS patients with and without high IgG, IgM, IgA titers against Chlamydia pneumoniae during 12 months' observation of AVS natural course].
Swierszcz J; Dubiel JS; Krzysiek J; Sztefko K; Galicka-Latała D; Roman P; Podolec P; Wodniecki J
Przegl Lek; 2011; 68(4):206-11. PubMed ID: 21853675
[TBL] [Abstract][Full Text] [Related]
6. [Body mass index influence on aortic valve stenosis].
Swierszcz J; Dubiel JS; Krzysiek J; Sztefko K; Galicka-Latała D; Pfitzner R; Podolec P; Wodniecki J
Przegl Lek; 2011; 68(2):87-91. PubMed ID: 21751516
[TBL] [Abstract][Full Text] [Related]
7. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis.
Basta G; Corciu AI; Vianello A; Del Turco S; Foffa I; Navarra T; Chiappino D; Berti S; Mazzone A
Atherosclerosis; 2010 Jun; 210(2):614-8. PubMed ID: 20074734
[TBL] [Abstract][Full Text] [Related]
8. Can serum lipid and CRP levels predict the "severity" of aortic valve stenosis?
Gunduz H; Akdemir R; Binak E; Tamer A; Keser N; Uyan C
Acta Cardiol; 2003 Aug; 58(4):321-6. PubMed ID: 12948037
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and antichlamydial antibodies in patients with metabolic syndrome.
Franco RR; Bodanese LC; Repetto G; Piccoli Jda C; Wiehe M; Bonato C; Duarte MM; Duarte T
Arq Bras Cardiol; 2011 Feb; 96(2):134-9. PubMed ID: 21109917
[TBL] [Abstract][Full Text] [Related]
10. Impact of carotid artery stenting on plasma interleukin-6, tumor necrosis factor-α and C-reactive protein.
Xia ZY; Yang H; Qu HQ; Cheng WD; Wang LX
Int Angiol; 2012 Feb; 31(1):28-32. PubMed ID: 22330622
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
Kaperonis EA; Liapis CD; Kakisis JD; Dimitroulis D; Papavassiliou VG; Perrea D; Kostakis AG
Eur J Vasc Endovasc Surg; 2006 May; 31(5):509-15. PubMed ID: 16427340
[TBL] [Abstract][Full Text] [Related]
12. [Aortic valve stenosis: persistence of infective agents or noninfective inflammatory process?].
Andropova OV; Polubentseva EI
Antibiot Khimioter; 2004; 49(11):28-30. PubMed ID: 15945547
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
[TBL] [Abstract][Full Text] [Related]
14. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.
Kaperonis EA; Liapis CD; Kakisis JD; Perrea D; Kostakis AG; Karayannakos PE
J Vasc Surg; 2006 Dec; 44(6):1198-204. PubMed ID: 17145421
[TBL] [Abstract][Full Text] [Related]
15. Time course of C-reactive protein, tumour necrosis factor-alpha and monocyte chemoattractant protein-1 following the surgical treatment of patients with aortic valve stenosis.
Kastellanos SS; Toumpoulis IK; Aggeli C; Zezas S; Chlapoutakis E; Kastellanos S; Stefanadis CI
Hellenic J Cardiol; 2007; 48(1):5-14. PubMed ID: 17388104
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, infection, and aortic valve sclerosis; Insights from the Olmsted County (Minnesota) population.
Agmon Y; Khandheria BK; Jamil Tajik A; Seward JB; Sicks JD; Fought AJ; O'Fallon WM; Smith TF; Wiebers DO; Meissner I
Atherosclerosis; 2004 Jun; 174(2):337-42. PubMed ID: 15136064
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB/c mice.
Isoda K; Matsuki T; Kondo H; Iwakura Y; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):708-15. PubMed ID: 20110570
[TBL] [Abstract][Full Text] [Related]
18. Association of Helicobacter pylori infection with systemic inflammation in preeclampsia.
UstUn Y; Engin-UstUn Y; Ozkaplan E; Otlu B; Sait TekerekoGlu M
J Matern Fetal Neonatal Med; 2010 Apr; 23(4):311-4. PubMed ID: 20222830
[TBL] [Abstract][Full Text] [Related]
19. Association of
Almeida NCC; Queiroz MAF; Lima SS; Brasil Costa I; Ayin Fossa MA; Vallinoto ACR; Ishak MOG; Ishak R
Front Immunol; 2019; 10():87. PubMed ID: 30804931
[TBL] [Abstract][Full Text] [Related]
20. Correlation of high sensitivity C-reactive protein and calcific aortic valve disease.
Jeevanantham V; Singh N; Izuora K; D'Souza JP; Hsi DH
Mayo Clin Proc; 2007 Feb; 82(2):171-4. PubMed ID: 17290723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
